THE PRACTICE GUIDELINES DEVELOPMENT CYCLE - A CONCEPTUAL TOOL FOR PRACTICE GUIDELINES DEVELOPMENT AND IMPLEMENTATION

被引:328
作者
BROWMAN, GP
LEVINE, MN
MOHIDE, EA
HAYWARD, RSA
PRITCHARD, KI
GAFNI, A
LAUPACIS, A
机构
[1] ONTARIO CANC TREATMENT & RES FDN, HAMILTON, ON, CANADA
[2] MCMASTER UNIV, DEPT MED, HAMILTON, ON L8N 3Z5, CANADA
[3] MCMASTER UNIV, SCH NURSING, HAMILTON, ON L8N 3Z5, CANADA
[4] UNIV TORONTO, SUNNYBROOK HLTH SCI CTR, DEPT MED, TORONTO, ON, CANADA
[5] OTTAWA CIVIC HOSP, LOEB MED RES INST, CLIN EPIDEMIOL UNIT, OTTAWA, ON K1Y 4E9, CANADA
关键词
D O I
10.1200/JCO.1995.13.2.502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To develop a conceptual tool for the systematic development of cancer treatment practice guidelines. Materials and Methods: The guidelines development tool, the Practice Guidelines Development Cycle, was derived from observing an evidence-based practice guidelines initiative at a comprehensive cancer center in Ontario, Canada, and from a literature review that uncovered barriers to guidelines development and implementation. Based on the literature findings and direct observations of how clinicians struggled with evidence based guidelines development, we evolved a framework to incorporate clinical and administrative factors (eg, costs) into evidence-based guidelines. Use of the practice Guidelines Development Cycle is illustrated with a clinical example (the use of adjuvant systemic therapy in good risk, node-negative premenopausal breast cancer patients). Results: The result is the Practice Guidelines Development Cycle, which consists of eight sequential steps, from topic selection to policy formulation. Independent validation of guidelines is included. The cycle products ore the evidence-based recommendation, the practice guideline, and the practice policy. The main features of the cycle are emphasis on scientific evidence, acknowledgment of the roles of clinical experience and nonclinical (administrative) factors through consensus, and explicit separation of clinical and cost considerations in guidelines development. Twenty guidelines are currently in development. Conclusion: Attention to the barriers of guidelines development the sociocultural nature of clinical practice, and respect for clinical experience, can lead proved strategies for guidelines development.
引用
收藏
页码:502 / 512
页数:11
相关论文
共 43 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
[Anonymous], 1992, Lancet, V339, P1
[3]   ECONOMIC-ANALYSIS IN PHASE-III CLINICAL CANCER TRIALS [J].
BENNETT, CL ;
ARMITAGE, JL ;
BUCHNER, D ;
GULATI, S .
CANCER INVESTIGATION, 1994, 12 (03) :336-342
[4]   PRACTICE GUIDELINES AND PRACTICING MEDICINE - ARE THEY COMPATIBLE [J].
BROOK, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (21) :3027-3030
[5]   EVIDENCE-BASED RECOMMENDATIONS AGAINST NEOADJUVANT CHEMOTHERAPY FOR ROUTINE MANAGEMENT OF PATIENTS WITH SQUAMOUS-CELL HEAD AND NECK-CANCER [J].
BROWMAN, GP .
CANCER INVESTIGATION, 1994, 12 (06) :662-670
[6]  
Canadian Task Force on the Periodic Health Examination, 1979, CAN MED ASSOC J, V121, P1193
[7]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[8]  
2-H
[9]   RANDOMIZED CLINICAL-TRIAL TO ASSESS THE EFFECTIVENESS OF BREAST IRRADIATION FOLLOWING LUMPECTOMY AND AXILLARY DISSECTION FOR NODE-NEGATIVE BREAST-CANCER [J].
CLARK, RM ;
MCCULLOCH, PB ;
LEVINE, MN ;
LIPA, M ;
WILKINSON, RH ;
MAHONEY, LJ ;
BASRUR, VR ;
NAIR, BD ;
MCDERMOT, RS ;
WONG, CS ;
CORBETT, PJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (09) :683-689
[10]   THE IMPACT OF READING ON PHYSICIANS NONADHERENCE TO RECOMMENDED STANDARDS OF MEDICAL-CARE [J].
COHEN, SJ ;
WEINBERGER, M ;
HUI, SL ;
TIERNEY, WM ;
MCDONALD, CJ .
SOCIAL SCIENCE & MEDICINE, 1985, 21 (08) :909-914